Evidence map›Paper›PMID 33671632›Full record

ArticleInternational journal of molecular sciences2021

EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning.

Georgiana Manica, Simona Ghenea, Cristian V A Munteanu, Eliza C Martin, Cristian Butnaru, Marius Surleac, Gabriela N Chiritoiu, Petruta R Alexandru, Andrei-Jose Petrescu, Stefana M Petrescu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Turnover of EDEM1, an ERAD-enhancing factor, is mediated by multiple degradation routes.Genes to cells : devoted to molecular & cellular mechanisms · 2024
    Article
  5. Intrinsically Disordered Proteins: An Overview.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Georgiana ManicaDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.
Simona GheneaDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0002-5566-0335
Cristian V A MunteanuDepartment of Bioinformatics and Structural Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0002-2998-0458
Eliza C MartinDepartment of Bioinformatics and Structural Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0002-3691-7537
Cristian ButnaruDepartment of Bioinformatics and Structural Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.
Marius SurleacDepartment of Bioinformatics and Structural Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0003-3218-4644
Gabriela N ChiritoiuDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0002-6321-6373
Petruta R AlexandruDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.
Andrei-Jose PetrescuDepartment of Bioinformatics and Structural Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.
Stefana M PetrescuDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.

Funding

Academia Româna Projects 1,2/2020Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-PCCDI-2018-1, PN-III-P1-1.1-PD-2019-1278, PN-III-P1-1.1-PD-2019-1036, PN-III-P1-1.1-PD2019-1242
6 · The paper itself

Abstract

EDEM3 recognizes and directs misfolded proteins to the ER-associated protein degradation (ERAD) process. EDEM3 was predicted to act as lectin or as a mannosidase because of its homology with the GH47 catalytic domain of the Man1B1, but the contribution of the other regions remained unresolved. Here, we dissect the molecular determinants governing EDEM3 function and its cellular interactions. LC/MS analysis indicates very few stable ER interactors, suggesting EDEM3 availability for transient substrate interactions. Sequence analysis reveals that EDEM3 consists of four consecutive modules defined as GH47, intermediate (IMD), protease-associated (PA), and intrinsically disordered (IDD) domain. Using an EDEM3 knock-out cell line, we expressed EDEM3 and domain deletion mutants to address EDEM3 function. We find that the mannosidase domain provides substrate binding even in the absence of mannose trimming and requires the IMD domain for folding. The PA and IDD domains deletions do not impair the trimming, but specifically modulate the turnover of two misfolded proteins, NHK and the soluble tyrosinase mutant. Hence, we demonstrate that EDEM3 provides a unique ERAD timing to misfolded glycoproteins, not only by its mannose trimming activity, but also by the positive and negative feedback modulated by the protease-associated and intrinsically disordered domain, respectively.

Indexed as

alpha 1-Antitrypsinalpha-MannosidaseCalcium-Binding ProteinsCatalytic DomainEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationHEK293 CellsHeLa CellsHumansMannoseMannosidasesMonophenol MonooxygenaseMutationProtein DomainsProtein FoldingProtein Interaction Mapsalpha 1-Antitrypsinalpha-MannosidaseCalcium-Binding ProteinsEDEM3 protein, humanEDEM3 protein, mouseMAN1B1 protein, humanMannoseMannosidasesMonophenol MonooxygenaseEDEM3ERADER mannosidasesintrinsically disordered domainMan1B1mass spectrometryNHKprotease-associated domaintyrosinase

Identifiers

PMID33671632
PMCPMC7926307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.